94 related articles for article (PubMed ID: 8623257)
1. Human xenoreactive natural antibodies against Gal alpha (1-3) pig terminal residues are not produced by CD5+ B-lymphocytes.
Pitre J; Möller E; Satake M
Transplant Proc; 1996 Apr; 28(2):545. PubMed ID: 8623257
[No Abstract] [Full Text] [Related]
2. Anti-pig antibody adsorption efficacy of {alpha}-Gal carrying recombinant P-selectin glycoprotein ligand-1/immunoglobulin chimeras increases with core 2 {beta}1, 6-N-acetylglucosaminyltransferase expression.
Liu J; Gustafsson A; Breimer ME; Kussak A; Holgersson J
Glycobiology; 2005 Jun; 15(6):571-83. PubMed ID: 15625182
[TBL] [Abstract][Full Text] [Related]
3. Human anti-B alloantibodies recognize xenoantigens on pig red blood cells and endothelial cells.
Gautreau C; Woimant G; Grosse H; Cardoso J; Soubrane O; Houssin D
Transplant Proc; 1996 Apr; 28(2):563. PubMed ID: 8623273
[No Abstract] [Full Text] [Related]
4. The humoral immune response in humans following ex vivo perfusion of porcine livers.
Cotterell AH; Collins BH; Parker W; Harland RC; Platt JL
Transplant Proc; 1996 Apr; 28(2):546. PubMed ID: 8623258
[No Abstract] [Full Text] [Related]
5. Characterization of xenoreactive natural antibodies: interactions with carbohydrate determinants.
Parker W; Lateef J; Everett ML; Bruno D; Platt JL
Transplant Proc; 1996 Apr; 28(2):548. PubMed ID: 8623260
[No Abstract] [Full Text] [Related]
6. Efficiency of different synthetic oligosaccharides for blocking the natural anti-g Gal antibodies found in human and baboon sera.
Oriol R; Neethling F; Joziasse D; Bovin N; Cooper DK
Transplant Proc; 1996 Apr; 28(2):562. PubMed ID: 8623272
[No Abstract] [Full Text] [Related]
7. Characterization of the human alpha 1,3Gal-reactive natural antibody population.
McMorrow IM; Comrack C; Sachs DH; Monroy R; DerSimonian H
Transplant Proc; 1996 Apr; 28(2):547. PubMed ID: 8623259
[No Abstract] [Full Text] [Related]
8. Does exposure to swine leukocyte antigens after pig-to-nonhuman primate xenotransplantation provoke antibodies that cross-react with human leukocyte antigens?
Key T; Schuurman HJ; Taylor CJ
Xenotransplantation; 2004 Sep; 11(5):452-6. PubMed ID: 15303982
[TBL] [Abstract][Full Text] [Related]
9. Rituximab as monotherapy for elicited xenoreactive antibody responses.
Gonzalez-Stawinski GV; Davis RD
J Heart Lung Transplant; 2006 Dec; 25(12):1462-6. PubMed ID: 17178342
[TBL] [Abstract][Full Text] [Related]
10. Biochemical analysis of the major pig xenoantigens recognised by humans.
Vaughan HA; Dabkowski PL; McKenzie IF; Sandrin MS
Transplant Proc; 1994 Jun; 26(3):1388-9. PubMed ID: 8029952
[No Abstract] [Full Text] [Related]
11. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate antigens of vascular endothelium and other pig tissues reacting with human natural antibodies.
Oriol R; Ye Y; Koren E; Cooper DK
Transplant Proc; 1994 Jun; 26(3):1398. PubMed ID: 8029957
[No Abstract] [Full Text] [Related]
13. Identification and characterization of a peptide mimeotope of galactose alpha 1,3 galactose.
Kooyman DL; McClellan SB; Parker WR; Avissar PL; Velardo MA; Nielsen DH; Platt JL; Logan JS
Transplant Proc; 1996 Apr; 28(2):554. PubMed ID: 8623265
[No Abstract] [Full Text] [Related]
14. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation.
Cairns T; Lee J; Goldberg LC; Hakim N; Cook T; Rydberg L; Samuelsson B; Taube D
Transplant Proc; 1996 Apr; 28(2):795-6. PubMed ID: 8623404
[No Abstract] [Full Text] [Related]
15. The effect of plasmapheresis and deoxyspergualin or cyclophosphamide treatment on anti-porcine Gal-alpha (1,3)-Gal antibody titres in humans.
Gannedahl G; Tufveson G; Sundberg B; Groth CG
Transplant Proc; 1996 Apr; 28(2):551. PubMed ID: 8623262
[No Abstract] [Full Text] [Related]
16. Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human antispecies antibodies.
Cairns T; Hammelmann W; Gray D; Welsh K; Larson G
Transplant Proc; 1994 Jun; 26(3):1279-80. PubMed ID: 7518125
[No Abstract] [Full Text] [Related]
17. Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal.
Alvarado CG; Cotterell AH; Parker W; Logan JS; Platt JL
Transplant Proc; 1996 Apr; 28(2):555. PubMed ID: 8623266
[No Abstract] [Full Text] [Related]
18. Confirmation of a major target epitope of human natural IgG and IgM anti-pig antibodies: terminal galactose alpha -1,3-galactose.
Cairns T; Karlsson E; Holgersson J; Taube D; Welsh K; Samuelsson G
Transplant Proc; 1994 Jun; 26(3):1384. PubMed ID: 7518131
[No Abstract] [Full Text] [Related]
19. Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands.
Parker W; Lateef J; Everett ML; Platt JL
Glycobiology; 1996 Jul; 6(5):499-506. PubMed ID: 8877370
[TBL] [Abstract][Full Text] [Related]
20. Biochemical analysis of pig xenoantigens detected by human antibodies.
Vaughan HA; Dabkowski PL; McKenzie IF; Sandrin MS
Transplant Proc; 1993 Oct; 25(5):2919-20. PubMed ID: 7692648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
